Delivery Order SPE2DB20D3303-SPE2DB25FA2NX
- Not listed
- The Defense Logistics Agency Troop Support Medical awarded a $5,035.78 firm fixed price delivery order contract to Amerisourcebergen Drug Corp Corporate Office Division to supply 4,562,164,295 Mesalamine ER 0.375 gram capsules, 120 count. The place of performance will be Amerisourcebergen's facility located in Conshohocken, Pennsylvania. The period of performance is short, spanning just one day from September 13, 2023 to September 14, 2023. No subcontractors or set aside designations were...
- The Defense Logistics Agency awarded a delivery order valued at $6,684.66 to AmerisourceBergen Drug Corp for 180 capsules of Mesalamine 400 mg, a medication commonly used to treat inflammatory bowel conditions. The contract is a firm fixed-price delivery order with an ultimate completion date of August 19, 2025, and was competitively awarded without any set-aside designation. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery...
- The Defense Logistics Agency awarded a $1,481.48 firm fixed price delivery order to AmerisourceBergen Drug Corp on July 28, 2025, for the supply of Mesalamine ER 0.375 gram capsules (120 count). This non-competitive delivery order is expected to be completed by July 29, 2025, with performance taking place at the vendor's corporate office location in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, for the supply of Mesalamine ER 0.375 gram capsules (120-count) with a contract value of $1,840.87. The order, issued on August 12, 2025, with completion targeted for August 13, 2025, represents a firm fixed-price delivery against an existing indefinite delivery contract. This award carries no set-aside designation and was...
- The Defense Logistics Agency awarded a delivery order valued at $1,993.43 to AmerisourceBergen Drug Corp for Mesalamine DR 400 mg capsules (180 count) on August 13, 2025, with an ultimate completion date of August 14, 2025. This competitively awarded, firm fixed-price delivery order represents a non-set-aside contract for pharmaceutical supply to support federal medical procurement needs. The product will be performed and delivered from AmerisourceBergen's corporate office located in...
- The Defense Logistics Agency awarded a firm fixed price delivery order valued at approximately $199,000 to Amerisourcebergen Drug Corporation for the supply of 120 capsules of 0.375 gram Mesalamine ER. The place of performance will be Amerisourcebergen's facility located in Conshohocken, Pennsylvania. The period of performance is August 15-16, 2023. This delivery order was issued against an existing DLA contract vehicle to fulfill requirements for this gastrointestinal drug, which is used to...
- The Defense Logistics Agency awarded a $5,414.95 firm fixed-price delivery order to AmerisourceBergen Drug Corp on July 30, 2025, for the supply of Mesalamine DR 1.2 GM tablets (120-count units). This is a non-set-aside, competitively awarded contract with an ultimate completion date of July 31, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract with...
- The Defense Logistics Agency awarded a delivery order valued at $1,286.99 to AmerisourceBergen Drug Corp for 120 tablets of Mesalamine DR 1.2 GM on August 15, 2025, with completion targeted for August 18, 2025. This firm fixed price delivery order represents a non-set-aside award issued under competitive procurement procedures. The product will be delivered to the contractor's corporate office location in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its headquarters as a major...
- The Defense Logistics Agency awarded a delivery order valued at $3,334.85 to AmerisourceBergen Drug Corp for the supply of Mesalamine DR 1.2 GM tablets (120-count units) on July 23, 2025, with an ultimate completion date of July 24, 2025. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and is performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania. The delivery order falls under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with...
- The Defense Logistics Agency Troop Support Medical awarded a $494,190 firm fixed price delivery order contract to Amerisourcebergen Drug Corporation for 4562313948 Mesalamine ER 0.375 gram capsules, 120 count. The place of performance is Amerisourcebergen's facility located in Conshohocken, Pennsylvania. The period of performance is September 26-27, 2023. No set aside designation or subcontractors are indicated. This delivery order was issued against an existing DLA medical supply vehicle to...
- SPE2DB20D3303Indefinite Delivery Contract
- SPE2DB20D3303-SPE2DB25FA2NXDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $3,841.26 to AmerisourceBergen Drug Corp for Mesalamine ER 0.375 gram capsules (120-count supply). This is a firm fixed price contract with no set-aside designation, awarded on August 14, 2025, with an ultimate completion date of August 15, 2025. The order will be fulfilled from AmerisourceBergen's Conshohocken, Pennsylvania location. Mesalamine is a gastrointestinal anti-inflammatory medication used to treat conditions such as ulcerative colitis and Crohn's disease. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The prime IDC serves as a comprehensive pharmaceutical supply vehicle providing medications and medical supplies to support military healthcare systems globally. AmerisourceBergen, as a major pharmaceutical distributor headquartered in Pennsylvania, has demonstrated capability to meet federal medical procurement requirements through competitive awards and maintains an extensive portfolio of pharmaceutical product deliveries supporting Defense Health Agency, U.S. Coast Guard, and other government healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.8k | 8/14/25 |